PPIC

Market Access

At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.

News

Skylark Bio has dosed the first patient in a phase 1/2 trial of SKY-GJB2, a gene therapy for the most common form of genetic deafness in children.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.